HOME >> BIOLOGY >> NEWS
$9M grant awarded to University of Cincinnati for bipolar disorder research

CINCINNATIResearchers at the University of Cincinnati (UC) have been awarded a $9 million five-year grant to find new ways to improve and personalize treatments for bipolar disorder, and to better understand how to identify this brain disorder earlier with the goal of preventing disease progression.

Bipolar disorder affects close to 6 million Americans each year and is recognized as one of the leading causes of disability worldwide.

The grant supports the formation of the Bipolar Disorder Imaging and Treatment Research Center (BITREC) at the UC College of Medicine and was awarded by the National Institute of Mental Health (NIMH) of the National Institutes of Health.

The causes of bipolar disorder are unclear, researchers say, so that determining the best treatment quickly for a given individual remains difficult and is largely based on educated trial-and-error of various medications that have been shown to improve symptoms in studies of large groups of affected individuals.

BITREC investigators, led by Stephen Strakowski, MD, professor and interim chairman of the department of psychiatry and director of the Center for Imaging Research, will use functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS)a technique used to measure the locations and amounts of specific brain chemicals based on their magnetic properties to study what bipolar disorder looks like in the brain, particularly in response to different treatments.

Bipolar disorder is a condition thats very dynamic, says Strakowski. Symptoms are progressive and frequently changing. To us, this suggests there are changes developing in the brain that impact how treatments will work during different times in the illness.

Strakowski says there are key areas in the brain where changes are occurring. These areas include the prefrontal cortical and subcortical brain regions that form the anterior limbic network, the system
'"/>

Contact: Dama Kimmon
dama.kimmon@uc.edu
513-558-4519
University of Cincinnati
26-Jul-2007


Page: 1 2

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Carnegie Mellons Peter Adams receives EPA research grant
3. New grants bolster efforts to generate faster and cheaper tools for DNA sequencing
4. $9 million EPSCoR grant to foster integrated research
5. UT and Atom Sciences Collaborate on NIH grant to develop test for major african disease
6. VIB scientist receives major research grant
7. New amfAR research grants to optimize HIV treatment
8. Wright State scientist receives grant to help clean up polluted American harbors
9. Ancient Etruscans were immigrants from Anatolia, or what is now Turkey
10. UCR biologist receives $1.75 million grant to study plant-threatening bacteria
11. FSU researchers reap $1-million grant to make medical implants safer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... 17, 2020 , ... Commercial launch readiness is a critical stage in a ... cure or vaccine, the global economic downturn will only increase price pressures overall for ... and capturing full value from every product launch is critical. However, history shows that ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint ... reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol ...
(Date:6/25/2020)... ... 24, 2020 , ... eClinical Solutions LLC , a ... accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) on ... severe COVID-19. This is the first study of an XPO1 inhibitor in patients ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... , ... July 17, 2020 , ... ... consulting firm for the life sciences and food industries, is pleased to announce ... of Clinical Research – Business Development. , Charles is an accomplished and results-driven ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, ... the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... procured purchasing contracts to its membership, recently named BioFit Engineered Products ... the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
Breaking Biology Technology:
Cached News: